Pharmacogenomics of Adverse Drug Reactions (ADRs)

  • 18k

    Total downloads

  • 83k

    Total views and downloads

About this Research Topic

Submission closed

Background

Pharmacogenomics can be defined in a broad sense as investigating the relationship between genomics and how single or different individuals vary in response to medication. This includes efficacy, dose adjustment, adverse reactions, and identifying novel medicinal targets. Research in pharmacogenomics has grown considerably in recent decades thanks to rapid advances in technology. However, it has had limited success in discovering genes that correspond to drug efficacy in most therapeutic areas, with the exception of oncology where somatic mutations in tumour tissues are often associated with treatment efficacy. As a result, much research in pharmacogenomics has been dedicated to adverse drug reactions (ADRs) but this has yet to be properly implemented in clinical practice. Pharmacogenomics of ADRs has tremendous potential to improve health outcomes since ADRs can lead to drug withdrawal leading to a cessation or delay in treatment. In addition, ADRs are estimated to be the 4th leading cause of death in the United States, causing more deaths than pulmonary disease, diabetes, AIDS, pneumonia and accidents. However, the exact number of ADRs is uncertain due to limitations in methodological considerations.
One lesson that has been learnt from the COVID19 pandemic is that under particular circumstances health care systems can fall short of resources. ADRs are a huge burden for health care systems worldwide, and a growing concern, due to the increase in the prevalence of multiple morbidities and the related use of medications. A considerable proportion of ADRs could be preventable with the implementation of precision medicine and the use of pharmacogenomics. The aim of this Research Topic is to provide a collection of papers that will ideally facilitate the implementation of pharmacogenomics to prevent ADRs. We welcome Original Research, Case Reports, and Review articles covering the following topics:
- Novel genetic associations with ADRs. Manuscripts that replicate/meta-analyse previous associations implementing robust methodologies are also welcome. Please note that we will take in consideration only association studies with a strong functional basis and with enough statistical power.
- Challenges (scientific, economic, or regulatory) in implementing pharmacogenomics to identify ADRs in clinical practice.
- The cost-effectiveness of using genomic tests to identify ADRs before prescribing a medication.
- Pharmacogenomics of ADRs in diverse populations or ethnicities, particularly the less studied ones.
- The molecular basis of ADRs that are reported to be associated with a genomic marker.
- Patients/clinicians attitude and knowledge about the pharmacogenomics of ADRs.

Topic Editor Hamid Mahmoudpour is employed by Merk KGaA. The other Topic Editors have no conflict of interest with the Research Topic theme

Research Topic Research topic image

Keywords: : Adverse Drug Reaction, Pharmacogenomics, Clinical Practice, Genomic Markers, Precision Medicine, Pharmacogenetics.

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Participating Journals

Impact

  • 83kTopic views
  • 63kArticle views
  • 18kArticle downloads
View impact